Proto Labs, Inc. PRLB 深 滬
等待開盤 08-22 09:30:00 美东时间
48.26
+0.560
+1.17%
華盛通- 最 高48.26
- 今 開47.45
- 成交量 11.81万股
- 最 低 47.05
- 昨 收 47.70
- 總市值 11.52亿
- 52周最高 49.39
- 市盈率 靜 73.33
- 換手率 0.49%
- 52周最低 26.345
- 委 比 -71.43%
- 總股本 2387.48万
- 歷史最高 286.57
- 量 比 0.77
- 振 幅 2.54%
- 歷史最低 22.04
- 每 手 1
- 風險率 5.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
ProPhase Labs, Inc. has been granted U.S. Patent No. 12379378-B2 for its biomarker-based systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma. This follows the successful validation of its BE-Smart™ molecular diagnostic, achieving over 95% technical success and compatibility with both brush and forceps biopsies, enhancing early detection. The patent, developed by inventors Joe Abdo, Sumeet K. Mittal,...
08-12 12:00
Proto Labs shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
Proto Labs shares are trading higher after the company reported better-than-exp...
07-31 20:57
Proto Labs Sees Q3 Adj EPS $0.35-$0.43 vs $0.37 Est; Sees Sales $130M-$138M vs $129.652M Est; Sees Q3 GAAP EPS $0.17-$0.25 vs $0.20 Est
Third Quarter 2025 OutlookIn the third quarter of 2025, the Company expects to generate revenue between $130.0 million and $138.0 million.The Company expects third quarter 2025 diluted net income per share between $0.17
07-31 18:02
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
Proto Labs Extends Consulting Agreement with Former CEO
Proto Labs ( ($PRLB) ) has shared an update. On May 20, 2025, Robert Bodor step...
05-31 04:52
Proto Labs announces CEO, president appointment; reaffirms guidance
Proto Labs (NYSE:PRLB) has appointed Suresh Krishna as president and chief executive officer and a member of the board, effective immediately. Krishna most recently served as president and CEO at Nort...
05-22 04:22
Proto Labs Reaffirms Q2 Revenue Outlook Of $124.0M - $132.0M; Still Sees Q2 GAAP EPS Of $0.11 - $0.19, And Non-GAAP EPS Between $0.30 And $0.38
Reaffirms Second Quarter 2025 OutlookProto Labs, Inc. ("Protolabs" or the "Company") (NYSE:PRLB), the world's leading provider of digital manufacturing services, today announced its Board of Directors has appointed
05-22 04:14
Proto Labs Appoints Suresh Krishna As President And CEO, Effective Immediately
Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE:PRLB), the world's leading provider of digital manufacturing services, today announced its Board of Directors has appointed Suresh Krishna as President and Chief
05-22 04:11
Exploring Proto Labs's Earnings Expectations
Proto Labs (NYSE:PRLB) is set to give its latest quarterly earnings report on F...
05-02 05:02
